Kalydeco to be landmark in cystic fibrosis treatment
February 1, 2012Vertex, cystic fibrosis, telaprevir
Vertex’s first-in-class treatment for cystic fibrosis Kalydeco has been approved by the FDA. The approval is a landmark in the …
NHS reforms criticised by healthcare journals
January 31, 2012Sales and Marketing BMJ, GPs, Lansley, NHS reforms, nursing times
A trio of leading healthcare journals has come out against the government’s NHS reforms. The British Medical Journal is leading …
Catalent expands controlled release drug development and supply capabilities at its Schorndorf, Germany Facility
January 31, 2012Manufacturing and Production
Somerset, NJ –January 25, 2012 — Catalent Pharma Solutions continues to expand its drug development and delivery capabilities to help …
Catalent acquires current minority interest in R.P. Scherer, Eberbach, Germany
January 31, 2012Manufacturing and Production
SOMERSET, NJ, January 30, 2012 – Catalent Pharma Solutions, a leading global drug delivery technology company, today announced the signing …
Ranbaxy taken to task by FDA over manufacturing woes
January 31, 2012Manufacturing and Production FDA, Ranbaxy, manufacturing, woes
Indian pharma company Ranbaxy will be banned from manufacturing drugs at certain plants for the US market until it corrects …
GMP issues affect Mircera, Xenical production at Roche plant
January 31, 2012Manufacturing and Production GMP, Mircera, Roche, Tamiflu, Xenical
Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …
Abbott slashes 700 jobs
January 31, 2012Manufacturing and Production, Sales and Marketing Abbott, FDA, manufacturing
Abbott Laboratories has said it will cut 700 jobs across its US and Puerto Rican operations, including hundreds of manufacturing …
Pharma manufacturing news in brief
January 31, 2012Manufacturing and Production Aptar Pharma, Granules-Omnichem, Lpath, Pii, Shemberg
Facility updates from Aptar Pharma, Granules-Omnichem and Pii, plus a fill/finish problem for Lpath and seaweed-based pharma capsules. Aptar Pharma …
Dietmar Leitner joins Napp Pharmaceuticals as its new managing director
January 31, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dietmar Leitner, Napp Pharmaceuticals
Dietmar Leitner has been appointed managing director of Napp Pharmaceuticals, part of the Napp Pharmaceutical Group. Dietmar has worked …
Roche’s Erivedge gains FDA approval
January 31, 2012Sales and Marketing Erivedge, FDA, Roche
The FDA has approved Roche’s Erivedge to treat patients with a common form of skin cancer. Erivedge (vismodegib) is now …
Misinformation charges against Servier dropped
January 30, 2012Sales and Marketing European Commission, Servier, anti-competitive behaviour
The European Commission has dropped a case against Servier in which the French manufacturer was accused of providing misleading information.The …
Pfizer in talks on Sandwich site sale
January 30, 2012Research and Development Pfizer, Sandwich
Pfizer has begun talks with a real estate investor to sell its R&D centre in Sandwich. The site was Pfizer’s …
PM Society celebrates new-look advertising awards
January 30, 2012Medical Communications, Sales and Marketing Creative Lynx, Daaichi Sankyo, PM Society Awards, Torre Lazur McCann
The PM Society has held its annual healthcare advertising awards, which this year saw some significant changes to award categories. …
FDA approves Pfizer cancer drug Inlyta
January 30, 2012Sales and Marketing Nexavar, Pfizer, Sutent, rcc, renal cell carcinoma
Pfizer’s kidney cancer drug Inlyta has gained US approval for second line treatment for the disease. Inlyta (axitinib) is now …
Government bites back against NHS reform naysayers
January 27, 2012Sales and Marketing BMJ, Lansley, NHS, reforms
The UK government has come out against healthcare groups that are opposing its plans to radically reform the NHS. Speaking …
Medical Research Network starts major global expansion programme
January 27, 2012Business Services
Leading unique Clinical Trial Support Organisation (CTSO), Medical Research Network (MRN), has completed the first stage of a major global …
James Murdoch steps down from GSK board
January 27, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Murdoch
GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will …
Boehringer broadens afatinib studies
January 27, 2012Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, afatinib
Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. …
Amgen buys Micromet for $1.2 billion
January 27, 2012Research and Development, Sales and Marketing Amgen. Micromet, blinatumomab
Amgen is to buy German biotech firm Micromet for $1.16 billion to broaden its mid-stage pipeline and consolidate its oncology …
AXON Communications appoints Tina Hahn as vice president
January 27, 2012Medical Communications AXON Communications, Tina Hahn
AXON Communications has announced the appointment of Dr Tina Hahn as vice president, based in Copenhagen, Denmark. In addition to …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
